Jpmorgan Chase & CO Maravai Lifesciences Holdings, Inc. Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 269,797 shares of MRVI stock, worth $982,061. This represents 0.0% of its overall portfolio holdings.

Number of Shares

269,797

Previous 269,797 -0.0%

Holding current value

$982,061

Previous $774,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	SELL	$2.03 - $2.89 $829,031 - $1.18 Million	-408,390 Reduced 60.22%	269,797 $774,000
Q1 2025 May 12, 2025	SELL	$2.21 - $6.13 $7.9 Million - $21.9 Million	-3,572,469 Reduced 84.05%	678,187 $1.5 Million
Q4 2024 Feb 12, 2025	BUY	$4.42 - $8.5 $885,816 - $1.7 Million	200,411 Added 4.95%	4,250,656 $23.2 Million
Q3 2024 Dec 26, 2024	BUY	$6.84 - $9.73 $25.5 Million - $36.3 Million	3,731,924 Added 1172.38%	4,050,245 $33.7 Million
Q3 2024 Nov 08, 2024	BUY	$6.84 - $9.73 $25.5 Million - $36.3 Million	3,731,924 Added 1172.38%	4,050,245 $33.7 Million

Q2 2024 Dec 26, 2024	SELL	$6.87 - $11.34 $25.6 Million - $42.3 Million	-3,731,924 Reduced 92.14%	318,321 $2.28 Million
Q2 2024 Aug 12, 2024	SELL	$6.87 - $11.34 $1.09 Million - $1.8 Million	-158,451 Reduced 33.23%	318,321 $2.28 Million
Q1 2024 Dec 26, 2024	SELL	$5.11 - $8.76 $18.3 Million - $31.3 Million	-3,573,473 Reduced 88.23%	476,772 $4.13 Million
Q1 2024 May 10, 2024	BUY	$5.11 - $8.76 $517,152 - $886,547	101,204 Added 26.95%	476,772 $4.13 Million
Q4 2023 Dec 26, 2024	SELL	$4.7 - $9.87 $17.3 Million - $36.3 Million	-3,674,677 Reduced 90.73%	375,568 $2.46 Million
Q4 2023 Feb 12, 2024	BUY	$4.7 - $9.87 $262,391 - $551,022	55,828 Added 17.46%	375,568 $2.46 Million
Q3 2023 Nov 14, 2023	SELL	$9.14 - $12.85 $74,061 - $104,123	-8,103 Reduced 2.47%	319,740 $3.2 Million
Q2 2023 Aug 11, 2023	SELL	$12.09 - $15.0 $43.1 Million - $53.4 Million	-3,562,634 Reduced 91.57%	327,843 $4.08 Million
Q1 2023 May 18, 2023	BUY	$12.99 - $16.48 $792,532 - $1.01 Million	61,011 Added 1.59%	3,890,477 $54.5 Million
Q1 2023 May 11, 2023	SELL	$12.99 - $16.48 $1.06 Million - $1.34 Million	-81,566 Reduced 2.09%	3,829,466 $53.7 Million
Q4 2022 Feb 13, 2023	BUY	$12.5 - $24.78 $4.08 Million - $8.08 Million	326,260 Added 9.1%	3,911,032 $56 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $1.12 Million - $1.65 Million	54,211 Added 1.54%	3,584,772 $91.5 Million
Q2 2022 Aug 11, 2022	BUY	$26.05 - $37.48 $3.54 Million - $5.1 Million	135,961 Added 4.01%	3,530,561 $100 Million
Q1 2022 May 11, 2022	SELL	$24.46 - $40.92 $2.85 Million - $4.77 Million	-116,607 Reduced 3.32%	3,394,600 $120 Million
Q4 2021 Feb 10, 2022	SELL	$35.0 - $45.94 $15.9 Million - $20.9 Million	-455,348 Reduced 11.48%	3,511,207 $147 Million
Q3 2021 Nov 12, 2021	BUY	$36.8 - $60.62 $146 Million - $240 Million	3,966,555 New	3,966,555 $195 Million

Others Institutions Holding MRVI

# of Institutions

182

Shares Held

132M

Call Options Held

688K

Put Options Held

11.6K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $479M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Maravai Lifesciences Holdings, Inc. Transaction History